Poster | Regulatory requirements for GMO applications

June 23, 2023

In the EU, a GMO is defined as an organism in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination.

Have look at the poster that ASPHALION experts prepared for the SETGYC congress about the “Regulatory requirements for genetically modified organism (GMO) applications: tips and tricks for global ATMP and vaccine development”.

Asphalion has participated in the following research projects funded by the European Union’s Horizon 2020 Research and Innovation programme: MISTRAL-HIV (No 847943), CardioReGenix (No 825670), RBDCOV (No 101046118), and UroPrint (No  964883); and on the Innovative Medicines Initiative 2 Joint Undertaking project ARDAT (No 945473), and on the Eurostars project Synchropace (ref. 115484 through the Innovative UK Project 600538).


For further information contact us at:

Search News & Events

  • Filter by category


Related news and events

NABIHEAL project | Progress meeting

ASPHALION is proud member of the NABIHEAL EU-funded project consortium, ensuring the compliance with regulatory standards during the pre-clinical development of the innovative NABIHEAL product development to facilitate future fast translation to clinical setting

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting